Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Amyloidosis, Transthyretin-Related”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Not applicableActive Not RecruitingNCT04869631
What this trial is testing

Screening for Amyloidosis Before Aortic Valve Elective Replacement

Who this might be right for
AmyloidosisAortic Valve Stenosis
Charite University, Berlin, Germany 1,000
Large-scale testing (Phase 3)Study completedNCT03862807
What this trial is testing

Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant

Who this might be right for
Amyloidosis, FamilialTransthyretin Amyloidosis
Alnylam Pharmaceuticals 24
Not applicableLooking for participantsNCT06845644
What this trial is testing

Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients

Who this might be right for
Charcot-Marie-Tooth Neuropathy Type 1AHereditary Transthyretin Amyloid NeuropathyAcquired Demyelinating Neuropathy
Assistance Publique Hopitaux De Marseille 120
Testing effectiveness (Phase 2)Study completedNCT05635045
What this trial is testing

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

Who this might be right for
Transthyretin Amyloidosis
Columbia University 10
Large-scale testing (Phase 3)Study completedNCT03997383
What this trial is testing

APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 360
Not applicableStudy completedNCT05311488
What this trial is testing

Early Detection of Neuropathy in ATTRv

Who this might be right for
Hereditary Amyloidosis, Transthyretin-Related
University of Pennsylvania 47
Post-approval studies (Phase 4)Ended earlyNCT04306510
What this trial is testing

Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN

Who this might be right for
Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics 8
Not applicableStudy completedNCT05560555
What this trial is testing

Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.

Who this might be right for
Hereditary Transthyretin Amyloidosis (ATTRv)Polyneuropathy
Pfizer 5
Not applicableWithdrawnNCT02713880
What this trial is testing

Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)

Who this might be right for
Transthyretin AmyloidosisTransthyretin-Related (ATTR) Familial Amyloid PolyneuropathyTransthyretin Amyloid Cardiopathy
CENTOGENE GmbH Rostock
Not applicableNot Yet RecruitingNCT06921408
What this trial is testing

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

Who this might be right for
Cardiac AmyloidosisTransthyretin Amyloidosis
University Hospital, Lille 57
Not applicableStudy completedNCT02792790
What this trial is testing

Carpal Tunnel Syndrome and Amyloid Cardiomyopathy

Who this might be right for
AmyloidosisCardiomyopathyTransthyretin Amyloidosis+2 more
The Cleveland Clinic 96
Testing effectiveness (Phase 2)Study completedNCT02191826
What this trial is testing

Study of SOM0226 in Familial Amyloid Polyneuropathy

Who this might be right for
Familial Amyloid Polyneuropathy (FAP)
SOM Innovation Biotech SA 17
Not applicableStudy completedNCT03886155
What this trial is testing

Cardiac Amyloidosis Screening at Trigger Finger Release

Who this might be right for
AmyloidosisTrigger FingerTransthyretin Amyloidosis+1 more
The Cleveland Clinic 107
Not applicableLooking for participantsNCT07213297
What this trial is testing

Comprehensive Program for Hereditary Transthyretin Amyloidosis

Who this might be right for
Amyloidosis in Transthyretin (TTR)Amyloidosis, Familial
Hospital de Alta Complejidad en Red 20
Not applicableWithdrawnNCT07080268
What this trial is testing

Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.

Who this might be right for
Amyloidosis in Transthyretin (TTR)Hereditary Amyloidosis, Transthyretin-Related
Hospital General de Niños Pedro de Elizalde
Not applicableStudy completedNCT03923920
What this trial is testing

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Who this might be right for
AmyloidAmyloidosisSpinal Stenosis+2 more
The Cleveland Clinic 200
Not applicableLooking for participantsNCT05489549
What this trial is testing

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Who this might be right for
Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, Familial+2 more
University of Texas Southwestern Medical Center 500
Post-approval studies (Phase 4)Looking for participantsNCT06940336
What this trial is testing

To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy

Who this might be right for
Transthyretin Amyloid Polyneuropathy
Qilu Pharmaceutical Co., Ltd. 15
Not applicableLooking for participantsNCT06907186
What this trial is testing

An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Hereditary Transthyretin Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07116473
What this trial is testing

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

Who this might be right for
Amyloidosis in Transthyretin (TTR)Amyloidosis, FamilialAmyloid Cardiomyopathy+7 more
Eidos Therapeutics, a BridgeBio company 250
Next Page